Cornerstone Financial Management LLC
Position in LYEL — Lyell Immunopharma, Inc.
CIK 2110329
PROVIDENCE, RI
Position in LYEL
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$922
-$493 QoQ
Shares Held
46
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LYEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cornerstone Financial Management LLC holds $188,264 across 66 Biotechnology names. LYEL ranks #34 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
184 | $82,163 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
171 | $16,629 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11 | $8,499 | |
| 4 | ERAS |
Erasca, Inc.
|
338 | $5,468 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
27 | $5,104 | |
| 6 | NUVL |
Nuvalent, Inc.
|
48 | $4,917 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14 | $4,632 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
14 | $3,616 |
All Filings in LYEL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $922 | 46 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,415 | 46 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||